Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (291-300 of 361) with videos related to

Pageof 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow TransplantationJan Styczynski, Gloria Tridello, Lidia Gil, et al.
Nature Communications|July 8, 2018
Genetic deficiency of NOD2 confers resistance to invasive aspergillosisMark S Gresnigt, Cristina Cunha, Martin Jaeger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2016
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMTSilke Heidenreich, Dimitris Ziagkos, Liesbeth C de Wreede, et al.
Blood Advances|January 4, 2018
Haploidentical transplant in patients with myelodysplastic syndromeMarie Robin, Raphael Porcher, Fabio Ciceri, et al.
Haematologica|July 3, 2025
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia ReportPedro Henrique Prata, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2019
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationNico Gagelmann, Diderik-Jan Eikema, Linda Koster, et al.
Blood|February 2, 2022
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndromeTim Grob, Adil S A Al Hinai, Mathijs A Sanders, et al.
Bone Marrow Transplantation|January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMaría Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
European Journal of Haematology|November 19, 2019
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWPPatrick J Hayden, Simona Iacobelli, José Antonio Pérez-Simón, et al.
Pageof 37

Showing results (291-300 of 361) with videos related to

Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow TransplantationJan Styczynski, Gloria Tridello, Lidia Gil, et al.
Nature Communications|July 8, 2018
Genetic deficiency of NOD2 confers resistance to invasive aspergillosisMark S Gresnigt, Cristina Cunha, Martin Jaeger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2016
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMTSilke Heidenreich, Dimitris Ziagkos, Liesbeth C de Wreede, et al.
Blood Advances|January 4, 2018
Haploidentical transplant in patients with myelodysplastic syndromeMarie Robin, Raphael Porcher, Fabio Ciceri, et al.
Haematologica|July 3, 2025
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia ReportPedro Henrique Prata, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2019
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationNico Gagelmann, Diderik-Jan Eikema, Linda Koster, et al.
Blood|February 2, 2022
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndromeTim Grob, Adil S A Al Hinai, Mathijs A Sanders, et al.
Bone Marrow Transplantation|January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMaría Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
European Journal of Haematology|November 19, 2019
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWPPatrick J Hayden, Simona Iacobelli, José Antonio Pérez-Simón, et al.
Pageof 37